ARTICLE | Clinical News

Daiichi submits Japanese application for esaxerenone

March 2, 2018 12:32 AM UTC

Exelixis Inc. (NASDAQ:EXEL) said Daiichi Sankyo Co. Ltd. (Tokyo:4568) submitted a regulatory application in Japan for esaxerenone (CS-3150) to treat hypertension, triggering a $20 million milestone payment to the South San Francisco company. The candidate is an oral non-steroidal mineralocorticoid receptor antagonist...